Northwestern Mutual Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.08M Buy
24,149
+1,883
+8% +$322K ﹤0.01% 872
2025
Q4
$3.76M Sell
22,266
-4,212
-16% -$684K ﹤0.01% 864
2025
Q3
$3.82M Sell
26,478
-2,264
-8% -$309K ﹤0.01% 820
2025
Q2
$3.64M Sell
28,742
-7,805
-21% -$958K ﹤0.01% 776
2025
Q1
$4.67M Sell
36,547
-1,893
-5% -$257K ﹤0.01% 673
2024
Q4
$5.08M Buy
38,440
+680
+2% +$95.6K ﹤0.01% 618
2024
Q3
$5.5M Buy
37,760
+128
+0.3% +$18.5K ﹤0.01% 597
2024
Q2
$5.17M Sell
37,632
-3,292
-8% -$439K 0.01% 582
2024
Q1
$5.62M Buy
40,924
+1,900
+5% +$259K 0.01% 536
2023
Q4
$5.3M Sell
39,024
-5,281
-12% -$644K 0.01% 528
2023
Q3
$5.42M Sell
44,305
-207
-0.5% -$26.3K 0.01% 488
2023
Q2
$5.65M Buy
44,512
+7,663
+21% +$995K 0.01% 475
2023
Q1
$4.76M Sell
36,849
-3,565
-9% -$467K 0.01% 495
2022
Q4
$5.31M Sell
40,414
-841
-2% -$109K 0.01% 459
2022
Q3
$4.83M Sell
41,255
-32,903
-44% -$4.09M 0.01% 432
2022
Q2
$8.72M Buy
74,158
+33,636
+83% +$3.99M 0.02% 314
2022
Q1
$5.28M Sell
40,522
-5,725
-12% -$746K 0.01% 424
2021
Q4
$7.06M Buy
46,247
+8,043
+21% +$1.25M 0.01% 353
2021
Q3
$6.18M Sell
38,204
-1,119
-3% -$188K 0.01% 349
2021
Q2
$6.43M Sell
39,323
-2,185
-5% -$337K 0.01% 325
2021
Q1
$6.25M Sell
41,508
-1,378
-3% -$219K 0.01% 303
2020
Q4
$6.5M Buy
42,886
+2,147
+5% +$307K 0.02% 280
2020
Q3
$5.52M Buy
40,739
+3,410
+9% +$463K 0.01% 285
2020
Q2
$5.1M Buy
37,329
+7,459
+25% +$951K 0.02% 275
2020
Q1
$3.22M Sell
29,870
-16,144
-35% -$1.86M 0.01% 306
2019
Q4
$5.54M Buy
46,014
+16,541
+56% +$1.85M 0.02% 255
2019
Q3
$2.93M Sell
29,473
-946
-3% -$99K 0.01% 325
2019
Q2
$3.32M Sell
30,419
-834
-3% -$88.7K 0.01% 303
2019
Q1
$3.5M Buy
31,253
+587
+2% +$64.4K 0.02% 286
2018
Q4
$2.96M Buy
30,666
+8,199
+36% +$870K 0.01% 293
2018
Q3
$2.74M Buy
22,467
+1,724
+8% +$203K 0.01% 282
2018
Q2
$2.28M Buy
20,743
+1,742
+9% +$186K 0.01% 293
2018
Q1
$2.03M Buy
19,001
+809
+4% +$89.7K 0.01% 292
2017
Q4
$1.94M Buy
18,192
+1,146
+7% +$122K 0.01% 282
2017
Q3
$1.9M Buy
17,046
+1,479
+10% +$158K 0.01% 272
2017
Q2
$1.61M Buy
15,567
+4,443
+40% +$438K 0.01% 282
2017
Q1
$1.09M Sell
11,124
-4,920
-31% -$471K 0.01% 319
2016
Q4
$1.42M Buy
16,044
+13,371
+500% +$1.22M 0.02% 285
2016
Q3
$258K Sell
2,673
-90,216
-97% -$8.58M 0.02% 167
2016
Q2
$7.97M Buy
92,889
+4,578
+5% +$411K 0.11% 129
2016
Q1
$7.68M Buy
88,311
+11,037
+14% +$987K 0.12% 126
2015
Q4
$8.71M Buy
77,274
+6,750
+10% +$733K 0.17% 109
2015
Q3
$7.13M Buy
70,524
+5,979
+9% +$717K 0.17% 116
2015
Q2
$7.94M Buy
64,545
+456
+0.7% +$54.6K 0.21% 91
2015
Q1
$7.34M Buy
64,089
+4,677
+8% +$516K 0.21% 99
2014
Q4
$6.01M Buy
59,412
+2,259
+4% +$220K 0.19% 109
2014
Q3
$5.21M Buy
57,153
+1,323
+2% +$116K 0.18% 109
2014
Q2
$4.78M Buy
+55,830
New +$4.4M 0.19% 103
2013
Q4
Sell
-339
Closed -$24K 1463
2013
Q3
$24K Buy
339
+42
+14% +$2.75K ﹤0.01% 710
2013
Q2
$17K Buy
+297
New +$17.2K ﹤0.01% 745

Other funds holding IBB

Northwestern Mutual Wealth Management's IBB Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 8.5% in Q1 2026, buying an estimated $322K and bringing the position to 24,149 shares worth $4.08M. The position accounts for ﹤0.01% of the portfolio, ranked #872.

Northwestern Mutual Wealth Management first reported a position in IBB in Q2 2013 and has held it in 50 quarters since. The position peaked at $8.72M in Q2 2022. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Northwestern Mutual Wealth Management held 24,149 shares of iShares Biotechnology ETF worth $4.08M as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 1,883 iShares Biotechnology ETF shares in Q1 2026, an estimated $322K.
  • iShares Biotechnology ETF made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #872 holding.
  • Northwestern Mutual Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 50 quarters since.
  • Northwestern Mutual Wealth Management's iShares Biotechnology ETF position peaked at $8.72M in Q2 2022.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.